Skip to main content

Advertisement

Table 3 Procedural characteristics (72 h) and device success (30 days)

From: The association of diabetes mellitus treated with oral antidiabetic drugs and insulin with mortality after transcatheter valve implantation: a 3-year follow-up of the TAVIK registry

  Without diabetes (n = 1337) Diabetes on OAD (n = 387) Diabetes on insulin (n = 276) p-value Adjusted OR (95% CI) Adjusted p-value
Device success (n, %) 1196 (89.5) 346 (89.4) 245 (88.8) 0.944 1.10 (0.64–1.91) 0.731
Gradient ≥ 20 mmHg (n, %) 39 (2.9) 14 (3.6) 7 (2.5) 0.228 1.10 (0.64–1.91) 0.731
Moderate or severe aortic insufficiency (n, %) 19 (1.4) 4 (1.0) 3 (1.1) 0.707 0.77 (0.32–1.87) 0.564
Malposition (n, %) 6 (0.4) 0 6 (2.2) 0.079 1.67 (0.52–5.35) 0.391
Second Valve (n, %) 44 (3.3) 14 (3.6) 7 (2.5) 0.607 0.96 (0.56–1.65) 0.881
Procedural mortality 72 h (n, %) 23 (1.7) 8 (2.1) 9 (3.3) 0.685 1.19 (0.62–2.27) 0.598
Early safety (n, %) 1165 (87.1) 326 (84.2) 234 (84.8) 0.258 1.26 (0.96–1.66) 0.096
  1. Adjustment of significant basic parameters (age, ejection fraction, previous CABG, coronary artery disease, major neurological deficits, renal disease and frailty) between patients with and without DM